Affiliation:
1. Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam
2. Pham Ngoc Thach Hospital for Tuberculosis and Lung Diseases, Huong Vuong, District 5, Ho Chi Minh City, Vietnam
Abstract
ABSTRACT
Vietnam is ranked 13th among the WHO list of 22 high-burden countries, based upon estimated total number of tuberculosis cases. Despite having a model national tuberculosis program, consistently achieving and exceeding WHO targets for detection and cure, drug-resistant and multidrug-resistant tuberculosis cases continue to rise. Rapid multidrug-resistant tests applicable in this setting, coupled with effective treatment regimens, would be a useful tool in reversing this trend, allowing early identification of patients with multidrug-resistant tuberculosis and avoiding resistance-amplifying regimens. Sequencing of consecutive isolates identified by the National Tuberculosis Program showed 89% of isoniazid-resistant isolates could be detected by targeting just 2 codons,
katG
315 and −15C→T in the
inhA
promoter, while rifampin resistance will be more complex to detect, with many different mutation and insertion events in
rpoB
. The most prevalent rifampin resistance-conferring mutations, as in other countries, were in
rpoB
codons 531 (43%), 526 (31%), and 516 (15%). However, a hybridization-based resistance test with probes targeting the 5 most common mutations would only detect 78% of rifampin-resistant isolates. Overall, these data suggest that rifampin resistance may be used as a surrogate marker for multidrug-resistant tuberculosis and that a sensitivity of between 70 to 80% may be possible for rapid molecular detection of multidrug-resistant tuberculosis in this setting.
Publisher
American Society for Microbiology
Reference36 articles.
1. Molecular Analysis of Isoniazid-Resistant
Mycobacterium tuberculosis
Isolates from England and Wales Reveals the Phylogenetic Significance of the
ahpC
−46A Polymorphism
2. Bertrand, T., N. A. Eady, J. N. Jones, Jesmin, J. M. Nagy, B. Jamart-Gregoire, E. L. Raven, and K. A. Brown. 2004. Crystal structure of Mycobacterium tuberculosis catalase-peroxidase. J. Biol. Chem.279:38991-38999.
3. Buu, T. N., K. Lonnroth, and H. T. Quy. 2003. Initial defaulting in the National Tuberculosis Programme in Ho Chi Minh City, Vietnam: a survey of extent, reasons and alternative actions taken following default. Int. J. Tuberc. Lung Dis.7:735-741.
4. Deretic, V., J. Song, and E. Pagan-Ramos. 1997. Loss of oxyR in Mycobacterium tuberculosis. Trends Microbiol.5:367-372.
5. DeRiemer, K., L. Garcia-Garcia, M. Bobadilla-del-Valle, M. Palacios-Martinez, A. Martinez-Gamboa, P. M. Small, J. Sifuentes-Osornio, and A. Ponce-de-Leon. 2005. Does DOTS work in populations with drug-resistant tuberculosis? Lancet365:1239-1245.
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献